Cargando…

RAGE and Modulation of Ischemic Injury in the Diabetic Myocardium

OBJECTIVE—Subjects with diabetes experience an increased risk of myocardial infarction and cardiac failure compared with nondiabetic age-matched individuals. The receptor for advanced glycation end products (RAGE) is upregulated in diabetic tissues. In this study, we tested the hypothesis that RAGE...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bucciarelli, Loredana G., Ananthakrishnan, Radha, Hwang, Yuying C., Kaneko, Michiyo, Song, Fei, Sell, David R., Strauch, Christopher, Monnier, Vincent M., Yan, Shi Fang, Schmidt, Ann Marie, Ramasamy, Ravichandran
Formato:	Texto
Lenguaje:	English
Publicado:	American Diabetes Association 2008
Materias:	Complications
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2453611/ https://www.ncbi.nlm.nih.gov/pubmed/18420491 http://dx.doi.org/10.2337/db07-0326

Ejemplares similares

Aldose Reductase Drives Hyperacetylation of Egr-1 in Hyperglycemia and Consequent Upregulation of Proinflammatory and Prothrombotic Signals
por: Vedantham, Srinivasan, et al.
Publicado: (2014)

Deletion of the Receptor for Advanced Glycation End Products Reduces Glomerulosclerosis and Preserves Renal Function in the Diabetic OVE26 Mouse
por: Reiniger, Nina, et al.
Publicado: (2010)

RAGE Deficiency Improves Postinjury Sciatic Nerve Regeneration in Type 1 Diabetic Mice
por: Juranek, Judyta K., et al.
Publicado: (2013)

Radical Roles for RAGE in the Pathogenesis of Oxidative Stress in Cardiovascular Diseases and Beyond
por: Daffu, Gurdip, et al.
Publicado: (2013)

Skin Advanced Glycation End Products Glucosepane and Methylglyoxal Hydroimidazolone Are Independently Associated With Long-term Microvascular Complication Progression of Type 1 Diabetes
por: Genuth, Saul, et al.
Publicado: (2015)

Receptor for Advanced Glycation End Products (RAGE) Deficiency Attenuates the Development of Atherosclerosis in Diabetes
por: Soro-Paavonen, Aino, et al.
Publicado: (2008)

Alagebrium Reduces Glomerular Fibrogenesis and Inflammation Beyond Preventing RAGE Activation in Diabetic Apolipoprotein E Knockout Mice
por: Watson, Anna M.D., et al.
Publicado: (2012)

RAGE Modulates Hypoxia/Reoxygenation Injury in Adult Murine Cardiomyocytes via JNK and GSK-3β Signaling Pathways
por: Shang, Linshan, et al.
Publicado: (2010)

Higher Plasma Soluble Receptor for Advanced Glycation End Products (sRAGE) Levels Are Associated With Incident Cardiovascular Disease and All-Cause Mortality in Type 1 Diabetes: A 12-Year Follow-Up Study
por: Nin, Johanna W.M., et al.
Publicado: (2010)

Plasma advanced glycation end products and the subsequent risk of microvascular complications in type 1 diabetes in the DCCT/EDIC
por: Monnier, Vincent M, et al.
Publicado: (2022)

Polyol pathway and modulation of ischemia-reperfusion injury in Type 2 diabetic BBZ rat hearts
por: Li, Qing, et al.
Publicado: (2008)

The Impact of Salsalate Treatment on Serum Levels of Advanced Glycation End Products in Type 2 Diabetes
por: Barzilay, Joshua I., et al.
Publicado: (2014)

The RAGE/DIAPH1 Signaling Axis & Implications for the Pathogenesis of Diabetic Complications
por: Ramasamy, Ravichandran, et al.
Publicado: (2022)

Increased Expression and Activity of 12-Lipoxygenase in Oxygen-Induced Ischemic Retinopathy and Proliferative Diabetic Retinopathy: Implications in Retinal Neovascularization
por: Al-Shabrawey, Mohamed, et al.
Publicado: (2011)

RAGE Regulates the Metabolic and Inflammatory Response to High-Fat Feeding in Mice
por: Song, Fei, et al.
Publicado: (2014)

Nitrite Anion Therapy Protects Against Chronic Ischemic Tissue Injury in db/db Diabetic Mice in a NO/VEGF-Dependent Manner
por: Bir, Shyamal C., et al.
Publicado: (2014)

Combined Effect of Inflammatory Gene Polymorphisms and the Risk of Ischemic Stroke in a Prospective Cohort of Subjects With Type 2 Diabetes: A Go-DARTS Study
por: Palmer, Colin N.A., et al.
Publicado: (2010)

High Glucose Induces Toll-Like Receptor Expression in Human Monocytes: Mechanism of Activation
por: Dasu, Mohan R., et al.
Publicado: (2008)

Catalase Deficiency Accelerates Diabetic Renal Injury Through Peroxisomal Dysfunction
por: Hwang, Inah, et al.
Publicado: (2012)

Perifornical Hypothalamic Orexin and Serotonin Modulate the Counterregulatory Response to Hypoglycemic and Glucoprivic Stimuli
por: Otlivanchik, Oleg, et al.
Publicado: (2015)

C-Peptide Prevents Hyperglycemia-Induced Endothelial Apoptosis Through Inhibition of Reactive Oxygen Species–Mediated Transglutaminase 2 Activation
por: Bhatt, Mahendra Prasad, et al.
Publicado: (2013)

The Role of Prostaglandins in Disrupted Gastric Motor Activity Associated With Type 2 Diabetes
por: Blair, Peter J., et al.
Publicado: (2019)

The Medial Amygdalar Nucleus: A Novel Glucose-Sensing Region That Modulates the Counterregulatory Response to Hypoglycemia
por: Zhou, Ligang, et al.
Publicado: (2010)

Inositol-Requiring Enzyme 1 Facilitates Diabetic Wound Healing Through Modulating MicroRNAs
por: Wang, Jie-Mei, et al.
Publicado: (2017)

Liver X Receptor Modulates Diabetic Retinopathy Outcome in a Mouse Model of Streptozotocin-Induced Diabetes
por: Hazra, Sugata, et al.
Publicado: (2012)

Activation of Hindbrain Neurons Is Mediated by Portal-Mesenteric Vein Glucosensors During Slow-Onset Hypoglycemia
por: Bohland, MaryAnn, et al.
Publicado: (2014)

A Novel Cellular Defect in Diabetes: Membrane Repair Failure
por: Howard, Amber C., et al.
Publicado: (2011)

Human Apolipoprotein(a) Kringle V Inhibits Ischemia-Induced Retinal Neovascularization via Suppression of Fibronectin-Mediated Angiogenesis
por: Lim, Yangmi, et al.
Publicado: (2012)

miR-92a Corrects CD34(+) Cell Dysfunction in Diabetes by Modulating Core Circadian Genes Involved in Progenitor Differentiation
por: Bhatwadekar, Ashay D., et al.
Publicado: (2015)

APPL1 Counteracts Obesity-Induced Vascular Insulin Resistance and Endothelial Dysfunction by Modulating the Endothelial Production of Nitric Oxide and Endothelin-1 in Mice
por: Wang, Yi, et al.
Publicado: (2011)

Glycation and a Spark of ALEs (Advanced Lipoxidation End Products) – Igniting RAGE/Diaphanous-1 and Cardiometabolic Disease
por: Arivazhagan, Lakshmi, et al.
Publicado: (2022)

Lysophosphatidic acid targets vascular and oncogenic pathways via RAGE signaling
por: Rai, Vivek, et al.
Publicado: (2012)

Animal models of ischemic limb ulcers: a systematic review and meta-analysis
por: Thanigaimani, Shivshankar, et al.
Publicado: (2020)

RAGE Suppresses ABCG1-Mediated Macrophage Cholesterol Efflux in Diabetes
por: Daffu, Gurdip, et al.
Publicado: (2015)

Aldose reductase modulates acute activation of mesenchymal markers via the β-catenin pathway during cardiac ischemia-reperfusion
por: Thiagarajan, Devi, et al.
Publicado: (2017)

Neuronatin: A New Inflammation Gene Expressed on the Aortic Endothelium of Diabetic Mice
por: Mzhavia, Nino, et al.
Publicado: (2008)

Potent Inhibition of Cicatricial Contraction in Proliferative Vitreoretinal Diseases by Statins
por: Kawahara, Shuhei, et al.
Publicado: (2008)

Correction of HDL Dysfunction in Individuals With Diabetes and the Haptoglobin 2-2 Genotype
por: Asleh, Rabea, et al.
Publicado: (2008)

Sulfasalazine Blocks the Development of Tactile Allodynia in Diabetic Rats
por: Berti-Mattera, Liliana N., et al.
Publicado: (2008)

Activation of NF-E2–Related Factor-2 Reverses Biochemical Dysfunction of Endothelial Cells Induced by Hyperglycemia Linked to Vascular Disease
por: Xue, Mingzhan, et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_ukdl2t6d5jmml7l7tbql0caqfs